Login/Sign Up
MRP ₹35
(Inclusive of all Taxes)
₹5.3 Cashback (15%)
Provide Delivery Location
About UROMITEXAN 200MG INJECTION 2ML
UROMITEXAN 200MG INJECTION 2ML belongs to a class of medication known as 'cytoprotectant' primarily used to prevent Hemorrhagic cystitis (a condition that causes bleeding in the urine due to the effect of anticancer agents (Ifosfamide). Our bodies degrade the anticancer drug (ifosfamide) to generate a compound (acrolein) that can injure and irritate the bladder. UROMITEXAN 200MG INJECTION 2ML decreases the risk of bladder irritation and bleeding caused by other anti-cancer drugs.
UROMITEXAN 200MG INJECTION 2ML contains 'Mesna', a chemo-protectant medicine that alters the breakdown of anti-cancer agents (Ifosfamide) found in the urine, making it less toxic. In addition, it binds to other urotoxic metabolites and inhibits their effects on the bladder.
UROMITEXAN 200MG INJECTION 2ML will be administered to your vein by a trained healthcare professional; hence, do not self-administer. In some cases, this medicine may cause certain side effects such as nausea, vomiting, headache, flushing (sense of warmth in the face, ears, neck, and trunk), lethargy, rash, diarrhea, light-headedness, abdominal pain, flu-like symptoms, fever, and injection site reactions. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
UROMITEXAN 200MG INJECTION 2ML is not recommended if you are allergic to it or any of its ingredients. An effective birth control measure should be taken to avoid pregnancy in women of a mother-bearing you’re your doctor may suggest regular urine and blood test while receiving UROMITEXAN 200MG INJECTION 2ML to monitor your CBC (blood cell count). UROMITEXAN 200MG INJECTION 2ML is not indicated for use in hematuria due to other underlying pathological conditions like thrombocytopenia. It is advised to drink at least 1-2 litres of fluid daily while receiving UROMITEXAN 200MG INJECTION 2ML. This medicine should be avoided in pregnant and breastfeeding populations due to serious side effects; hence inform your doctor before administration.
Uses of UROMITEXAN 200MG INJECTION 2ML
Have a query?
Directions for Use
Medicinal Benefits
UROMITEXAN 200MG INJECTION 2ML belongs to a class of medication known as 'chemoprotectant' primarily used to prevent bleeding into the urine by a particular anticancer medicine known as ifosfamide (ifosfamide-induced hemorrhagic cystitis). It also reduces the risk of inflammation and bleeding in the bladder by receiving anti-cancer medication. It contains Mesna, which works by reacting chemically with the urotoxic ifosfamide (anti-cancer medicines) metabolites, resulting in their detoxification. In addition, it binds to other urotoxic metabolites and inhibits their effects on the bladder.
How UROMITEXAN 200MG INJECTION 2ML Works
Storage
What if I have taken an overdose of UROMITEXAN 200MG INJECTION 2ML
Drug Warnings
Do not take this injection if you are allergic to UROMITEXAN 200MG INJECTION 2ML or any of its ingredients. An effective birth control method should be used to avoid pregnancy in women of childbearing age. Maintain a three-month gap between your last dose of UROMITEXAN 200MG INJECTION 2ML and your next pregnancy. Regular urine and blood test should be done while receiving UROMITEXAN 200MG INJECTION 2ML to monitor your CBC (blood cell count). It is not indicated for use in hematuria due to other underlying pathological conditions like thrombocytopenia. This medicine is known to cause blurry vision and dizziness, so do not drive or operate machinery.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
Avoid consumption of alcohol while on treatment with UROMITEXAN 200MG INJECTION 2ML as it may lead to serious side effects.
Pregnancy
Unsafe
UROMITEXAN 200MG INJECTION 2ML is not recommended to be used in pregnancy as it may cause serious side effects. Use effective birth control measures before starting the treatment with Ifosamide and for 3 months after completing the treatment. If you get pregnant while you are receiving UROMITEXAN 200MG INJECTION 2ML, inform your doctor.
Breast Feeding
Unsafe
UROMITEXAN 200MG INJECTION 2ML should not be used if you are breastfeeding as it is known to pass through the breast milk and harm your infant. Do not breastfeed for at least one week following your last dosage of mesna or ifosfamide.
Driving
Unsafe
UROMITEXAN 200MG INJECTION 2ML is known to cause blurred vision and drowsiness. So, do not drive or operate machinery, which requires mental alertness.
Liver
Caution
Let your doctor know if you have any history of liver diseases before receiving UROMITEXAN 200MG INJECTION 2ML.
Kidney
Caution
Let your doctor know if you have any history of kidney diseases before receiving UROMITEXAN 200MG INJECTION 2ML. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Children
Caution
The safety and efficacy of UROMITEXAN 200MG INJECTION 2ML in children have not been established. Moreover, UROMITEXAN 200MG INJECTION 2ML contains benzyl alcohol, which is known to cause a gasping syndrome in children. Hence, use is not recommended.
UROMITEXAN 200MG INJECTION 2ML is used to treat Ifosfamide-induced hemorrhagic cystitis.
Our body breaks down anticancer agents like ifosfamide or cyclophosphamide to form a chemical known as acrolein, which can harm and irritate the bladder. UROMITEXAN 200MG INJECTION 2ML works by making this natural chemical less harmful or toxic. However, UROMITEXAN 200MG INJECTION 2ML does not change ifosfamide's anti-cancer effects.
No, UROMITEXAN 200MG INJECTION 2ML should not be taken with an anti-coagulant like warfarin, heparin or coumarin as it might increase the risk of bleeding and lead to serious complications.
An autoimmune disorder is a condition in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage. Some autoimmune disorders are rheumatoid arthritis, systemic lupus erythematosus or nephritis.
Please inform your doctor if you observe any change in the urine colour (like if you have red/pink-coloured urine).
In addition to bladder bleeding in hemorrhagic cystitis, an individual might also experience bladder wall scarring, decreased bladder size (atrophy), severe systemic infection (urosepsis), and urinary obstruction.
UROMITEXAN 200MG INJECTION 2ML is given with ifosfamide or cyclophosphamide to prevent haemorrhagic cystitis which is a serious side effect caused by the toxic metabolite acrolein produced when these drugs are metabolized.
Yes, UROMITEXAN 200MG INJECTION 2ML is compatible with potassium chloride and doxorubicin. Though no interactions were found, it is advised to consult the doctor before taking UROMITEXAN 200MG INJECTION 2ML with potassium chloride and doxorubicin.
No, UROMITEXAN 200MG INJECTION 2ML is not a chemotherapy drug by itself. However, it is used along with chemotherapy drugs like Ifosfamide to prevent haemorrhagic cystitis, a side effect caused by the toxic metabolites of Ifosfamide, such as acrolein.
No, UROMITEXAN 200MG INJECTION 2ML is not cytotoxic. It is used as a chemo protectant, mainly to prevent haemorrhagic cystitis caused by chemotherapy drugs. It protects the bladder from damage by detoxifying toxic metabolites such as acrolein. UROMITEXAN 200MG INJECTION 2ML itself does not have cytotoxic effects, it is administered with cytotoxic drugs.
No, UROMITEXAN 200MG INJECTION 2ML is not a vesicant. Instead, UROMITEXAN 200MG INJECTION 2ML serves as a chemo protectant to safeguard the bladder from toxic metabolites produced by chemotherapy drugs, particularly preventing haemorrhagic cystitis.
The side effects of UROMITEXAN 200MG INJECTION 2ML include headache, nausea, vomiting, fever, diarrhoea, lethargy, flushing (sense of warmth in the face, ears, neck, and trunk), rash, light-headedness, abdominal pain, flu-like symptoms, and injection site reactions. Consult the doctor if any of these symptoms persist or worsen.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd